writing.clarifi.fi - Part of the Clarifi Group

Your Ideas. Perfectly Written.

Clarifi Ghostwriting helps founders, scientists, and executives share ideas that sound like them — authentic, precise, and professionally written.

Part of the Clarifi Group

Thought Leadership, Done Right

We create writing that reflects your expertise and builds trust.Typical projects:
- LinkedIn posts & long-form articles
- Op-eds for tech, policy, or health media
- Keynote speeches & event scripts
- White papers, reports, & investor updates

CLARIFI.FI

Your Voice, Our Pen

You speak; we listen, draft, and refine.
Through short calls or voice notes, we capture your ideas, clarify structure, and deliver content ready for publication.
No AI clichés — just human insight and narrative discipline.

CLARIFI.FI

Who It's For

- Startup founders & executives
- Scientists & researchers
- Policy & advocacy professionals
- Thought leaders seeking consistent online presence

---

CLARIFI.FI

Why Clarifi

Our background in regulation, science, and storytelling lets us handle complexity without losing clarity.
We make technical ideas understandable without dumbing them down.

Get In Touch

Ready to grow your voice and reach?
Let’s build your content pipeline.
Schedule a short intro call or request sample work. Get in touch below or at info(at)clarifi.fi

Submit

Clarifi in the Media

Insights and features on how regulation, innovation, and startup strategy intersect — from MedTech to FoodTech and beyond.Startups don’t just need tech leads: They need an integrator.
Feature for EU-Startups
Read →Confidential by Default? The Transparency Dilemma in Europe’s Novel Foods System.
Feature for Green Queen Media
Read →From Gatekeeping to Guiding: The Case for Collaborative Regulation in Mission-Driven Innovation
White Paper in Collaboration with GCI
Read →Digital Health Meets Red Tape: What Pharma Can Learn from Software as a Medical Device
The role of SaMD in pharma covering regulations, AI/ML risks, compliance, and digital health strategies.
Feature for PharmaNow
Read →Lessons from a €50 million Series B: And why it matters at every startup funding stage
Feature for EU-Startups
Read →What does Gourmey’s regulatory milestone mean for cell-cultivated meat?
Interviewed by FI Global Insights
Read →Why EU Innovators Face Growing Barriers With EU Combination Product Regulation
Interviewed by Medtech Insight
Read →From WHOOP to DiGA: Where the Wellness Line Becomes a Regulatory Minefield
Feature for Test Labs UK Outlook
Read →Guest article: EU novel food delays. Why bureaucracy is choking off food innovation
Feature for AgFunder News
Read →How AI can get your novel food approved faster
Interviewed by FoodNavigator Europe
Read →Apple vs WHOOP: Two Blood Pressure Strategies, Two Very Different Regulatory Journeys
Feature for Test Labs UK Outlook
Read →For interviews, collaborations, or speaking opportunities, contact info(at)clarifi.fi